Skip to content
MarketScale
‹ Back to IndustriesHealthcare

M&A Healthcare Advisors (MAHA) Exclusively Represents Hoover Pharmacy in their Sale to CVS

LOS ANGELES, March 28, 2023 /PRNewswire/ — M&A Healthcare Advisors (MAHA), a boutique merger and acquisition (M&A) advisory group, is proud to announce the sale of Hoover Pharmacy, a Specialty & Retail Pharmacy based in the San Francisco Bay area focused on serving Stanford Medical Campus patients. Hoover Pharmacy’s files were acquired by CVS and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
M&A Healthcare Advisors (MAHA) Exclusively Represents Hoover Pharmacy in their Sale to CVS

LOS ANGELES, March 28, 2023 /PRNewswire/ — M&A Healthcare Advisors (MAHA), a boutique merger and acquisition (M&A) advisory group, is proud to announce the sale of Hoover Pharmacy, a Specialty & Retail Pharmacy based in the San Francisco Bay area focused on serving Stanford Medical Campus patients. Hoover Pharmacy’s files were acquired by CVS and all patients will now receive dispensing service at their local Palo Alto branch.

“Andre and his team were instrumental in driving value for our pharmacy and securing the ideal buyer to meet our specific sale criteria. His reliable and consistent guidance allowed us to focus on maintaining operations throughout the transaction while introducing a buyer that would faithfully continue our legacy of care with our patients across the bay area”, Jonathan Han, COO of Hoover Pharmacy.

While there is currently a sense of uncertainty in the larger economy, healthcare M&A remains active with the successful acquisition of Hoover being another great example of the resiliency of lower-middle market healthcare. The team at M&A Healthcare Advisors provided attentive and expert guidance, allowing the Hoover ownership team to achieve their unique sale goals on the identified timeline.

“We are very proud of the level of service we provide to our clients and the successful and efficient sale of Hoover Pharmacy speaks to the client-centric focus we strive for as an organization. Andre’s contributions and representation of the Hoover ownership team was commendable and demonstrates our belief that having an experienced and dedicated sell side advisor greatly increases the probability of achieving a successful outcome”, say Co-Founders Mark Thomas & Mike Moran.

This sale continues the tradition of excellence put in place by M&A Healthcare Advisors.

About M&A Healthcare Advisors

M&A Healthcare Advisors (MAHA), is a boutique merger and acquisition (M&A) advisory group, focused on the lower-middle market healthcare industry. Their core purpose is to provide comprehensive, efficient, and committed transactional support for emerging or established, lower-middle market healthcare businesses.

The team at M&A Healthcare Advisors has sold companies in a variety of healthcare segments: Behavioral Health, Autism Services, I/DD, Hospice, Home Health, Home Care, Private Duty, Physical Therapy, Staffing/Medical Recruiting, Facility-Based Care, Not-for-Profits, and all types of Pharmacy. Their full suite of services includes Sell-Side Representation, M&A Hourly Consulting, and Expert Valuation services.

Business Contact

Mark Thomas

Partner, Director of Operations

M&A Healthcare Advisors

mthomas@mahealthcareadvisors.com

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Leading with Purpose: Dr. David Foster on Faith, Healthcare Leadership, and Physician Collaboration

Dr. David Foster discusses the importance of faith in healthcare leadership and the role of physician collaboration. The conversation emphasizes how values-driven leadership can positively impact patient care. The dialogue also explores the significance of integrating personal beliefs in professional settings.

  • 01Values-driven leadership can significantly enhance patient care.
  • 02Integrating personal beliefs in professional settings can benefit healthcare leadership.
  • 03Collaboration among physicians is crucial for effective healthcare leadership.

Aug 4, 2026

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512